Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ZAC 170
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
RH Bophelo Limited invests in healthcare sector in South Africa. It primarily invests in equity, quasi-equity, and equity related investments in operational infrastructure, including health insurance, private hospital-related infrastructure, pharmaceuticals, and retail and distribution sectors. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited is a subsidiary of...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Data is available to registered users only
